LivaNova PLC - Ordinary Shares (LIVN)
94.19
+14.29 (17.88%)
NASDAQ · Last Trade: Nov 4th, 11:15 PM EST
LivaNova (LIVN) Q3 2026 Earnings Call Transcriptfool.com
Capital spending rose as demand held firm and a large payment shifted.
Via The Motley Fool · November 4, 2026
LivaNova Q3 Earnings Call Highlightsmarketbeat.com
LivaNova (NASDAQ:LIVN) reported third-quarter 2026 revenue growth of 10% from the prior-year period, driven by double-digit gains in its Cardiopulmonary and epilepsy businesses. The medical technology company raised its full-year revenue and adjusted earnings outlook, citing commercial execution, he
Via MarketBeat · November 4, 2026
LivaNova (NASDAQ:LIVN) Q3 2026: Adjusted EPS Beat, Revenue Inline, Guidance Raisedchartmill.com
Via Chartmill · November 4, 2026
LivaNova (NASDAQ:LIVN): Strong Growth Meets a Technical Breakout Setupchartmill.com
Via Chartmill · November 3, 2026
LivaNova PLC (NASDAQ:LIVN): An Affordable Growth Candidate With Reasonable Valuationchartmill.com
Via Chartmill · October 21, 2026
LivaNova PLC (NASDAQ:LIVN): Strong Growth Meets a High-Quality Technical Setupchartmill.com
Via Chartmill · October 10, 2026
LivaNova PLC (NASDAQ:LIVN) Combines Strong Growth With a Timely Technical Setupchartmill.com
Via Chartmill · September 9, 2026
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuationchartmill.com
Via Chartmill · September 7, 2026
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setupchartmill.com
Via Chartmill · August 18, 2026
LivaNova (NASDAQ:LIVN) Beats Q2 Earnings Estimates and Raises Full-Year Guidancechartmill.com
Via Chartmill · August 5, 2026
LivaNova Director Sells 1,650 Shares for $131,500fool.com
The insider sold 1,650 shares but still retains nearly 8,000 shares.
Via The Motley Fool · September 10, 2026
LivaNova (LIVN) Q2 2026 Earnings Call Transcriptfool.com
Record quarterly revenue driven by Essenz upgrades and oxygenator market share gains.
Via The Motley Fool · August 12, 2026
LivaNova Q2 Earnings Call Highlightsmarketbeat.com
LivaNova (NASDAQ:LIVN) reported record quarterly revenue and adjusted earnings per share for the second quarter of 2026, citing double-digit reported growth across its Cardiopulmonary and Epilepsy businesses. The company raised its full-year revenue and adjusted EPS outlook while reducing its adjust
Via MarketBeat · August 5, 2026
LivaNova (NASDAQ:LIVN): A Strong Growth Stock with a Constructive Technical Setupchartmill.com
Via Chartmill · July 27, 2026
LivaNova (NASDAQ:LIVN) Fits the Affordable Growth Profile with Strong Earnings and Relative Valuechartmill.com
Via Chartmill · July 21, 2026
LivaNova Plc (NASDAQ:LIVN) combines fundamental strength and technical timing for a potential breakout.chartmill.com
Via Chartmill · July 1, 2026
LivaNova PLC (NASDAQ:LIVN) Beats Q1 Estimates, Lifts Full-Year Guidancechartmill.com
Via Chartmill · May 6, 2026
LivaNova (LIVN) Q1 2025 Earnings Transcriptfool.com
LivaNova (LIVN) Q1 2025 Earnings Transcript
Via The Motley Fool · May 7, 2026
LivaNova (LIVN) Q2 2025 Earnings Transcriptfool.com
LivaNova (LIVN) Q2 2025 Earnings Transcript
Via The Motley Fool · May 6, 2026
LivaNova (LIVN) Q3 2025 Earnings Transcriptfool.com
LivaNova (LIVN) Q3 2025 Earnings Transcript
Via The Motley Fool · May 6, 2026
LivaNova (NASDAQ:LIVN) Beats Q4 Estimates, Provides Steady 2026 Outlookchartmill.com
Via Chartmill · February 25, 2026
LivaNova (LIVN) Q1 2026 Earnings Transcriptfool.com
LivaNova (LIVN) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
LivaNova (LIVN) Q4 2025 Earnings Call Transcriptfool.com
LivaNova (LIVN) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 25, 2026
LivaNova PLC (NASDAQ:LIVN) Beats Q3 2025 Estimates and Raises Full-Year Guidancechartmill.com
LivaNova (LIVN) beat Q3 2025 earnings and revenue estimates, raising its full-year guidance on strong performance across its Cardiopulmonary and Neuromodulation segments.
Via Chartmill · November 5, 2025